Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.48 +0.03 (+1.22%)
At close: Nov 11, 2026 · 4:00 PM EST

Rocket Pharmaceuticals (RCKT) Depreciation & Amortization (CF) (2015 - 2026)

Updated

Rocket Pharmaceuticals' Depreciation & Amortization (CF) came in at $1.56 million for Q2 2026, down 23.3% from $2.04 million a year earlier and down 2.7% from the prior quarter.

Analysis

Rocket Pharmaceuticals (RCKT) Depreciation & Amortization (CF) (2015 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Rocket Pharmaceuticals reported Depreciation & Amortization (CF) of $7.55 million, down 7.5% year-over-year; for FY2025, it came in at $8.87 million, up 22.9% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last ten years, with a five-year compound annual growth rate of 50.6% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $7.22 million in FY2024 (+46.1%), $4.94 million in FY2023 (+25.7%), $3.93 million in FY2022 (+21.4%) and $3.24 million in FY2021 (+183.0%).
  • The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q4 2023.
  • Year-over-year, Depreciation & Amortization (CF) has declined for three consecutive quarters, with growth averaging 14.6% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2021 (growth of 166.7%), and the weakest in Q1 2026 (a decline of 34.4%).
  • Business Quant data shows RCKT's Depreciation & Amortization (CF) at $1.61 million (Q1 2026), $1.68 million (Q4 2025) and $2.7 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Rocket Pharmaceuticals 268.37 Mn -15.33 Mn - 1.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.56 Mn
Mar 31, 2026 1.61 Mn
Dec 31, 2025 1.68 Mn
Sep 30, 2025 2.70 Mn
Jun 30, 2025 2.04 Mn
Mar 31, 2025 2.45 Mn
Dec 31, 2024 1.82 Mn
Sep 30, 2024 1.85 Mn
Jun 30, 2024 1.83 Mn
Mar 31, 2024 1.72 Mn
Dec 31, 2023 1.40 Mn
Sep 30, 2023 1.22 Mn
Jun 30, 2023 1.19 Mn
Mar 31, 2023 1.14 Mn
Dec 31, 2022 1.05 Mn
Sep 30, 2022 1.08 Mn
Jun 30, 2022 1.00 Mn
Mar 31, 2022 800,000.00
Dec 31, 2021 1.04 Mn
Sep 30, 2021 800,000.00
API Access

Rocket Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RCKT&period=max&api_key=YOUR_API_KEY